Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 4:40 pm Purchase | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 4,508,579 11.17% | 3,672,120 (+439.01%) | View |
| 2024-04-01 6:38 pm Unchanged | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 13,956,685 18.64% | 0 (Unchanged) | View |
| 2024-04-01 6:34 pm Sale | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,957,385 9.99% | -3,362 (-0.11%) | View |
| 2024-04-01 6:30 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 9,986,556 9.9% | -31,519 (-0.31%) | View |
| 2024-04-01 5:42 pm Sale | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 4,762,558 9.99% | -640,495 (-11.85%) | View |
| 2024-03-27 4:37 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 10,018,075 9.9% | -13,061,066 (-56.59%) | View |
| 2024-02-16 6:55 pm Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 23,079,141 18.89% | 3,116,577 (+15.61%) | View |
| 2024-02-14 3:49 pm Sale | 13G | NUVALENT INC NUVL | Fairmount Funds Management LLC | 1,924,626 3.4% | -864,355 (-30.99%) | View |
| 2024-02-14 3:48 pm Sale | 13G | TREVI THERAPEUTICS INC TRVI | Fairmount Funds Management LLC | 0 0% | -6,018,465 (Position Closed) | View |
| 2024-02-14 3:48 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Fairmount Funds Management LLC | 3,633,965 9.9% | 1,732,568 (+91.12%) | View |
| 2024-02-14 3:47 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Fairmount Funds Management LLC | 6,632,015 9.9% | 1,362,728 (+25.86%) | View |
| 2024-02-14 3:46 pm Purchase | 13G | AXSOME THERAPEUTICS INC AXSM | Fairmount Funds Management LLC | 2,360,077 4.9% | 15,097 (+0.64%) | View |
| 2024-02-14 3:46 pm Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Fairmount Funds Management LLC | 2,883,221 8.1% | 740,169 (+34.54%) | View |
| 2024-02-14 3:45 pm Sale | 13G | ANNEXON INC ANNX | Fairmount Funds Management LLC | 322,893 0.4% | -3,358,563 (-91.23%) | View |
| 2024-02-14 3:45 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | Fairmount Funds Management LLC | 2,131,369 5.2% | 6,744 (+0.32%) | View |
| 2024-01-31 4:30 pm Purchase | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 5,403,053 9.99% | 1,496,851 (+38.32%) | View |
| 2024-01-24 5:26 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,960,747 9.9% | 1,086,914 (+58.00%) | View |
| 2024-01-24 5:12 pm Purchase | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 13,956,685 19.43% | 1,192,292 (+9.34%) | View |
| 2023-12-29 5:00 pm Sale | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 836,459 2.32% | -2,977,442 (-78.07%) | View |
| 2023-12-11 5:21 pm Unchanged | 13D | SPYRE THERAPEUTICS, INC SYRE | Fairmount Funds Management LLC | 3,813,901 10.59% | 0 (Unchanged) | View |